Clinical Trial Update: Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of OPK-88006 in healthy volunteers and individuals presumed to have metabolic dysfunction-associated steatohepatitis (MASH); the trial is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• OPK-88006

Snippet

Sponsor: OPKO Health, Inc. | Conditions: MASH | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING